If the Reds were still thinking of putting Aroldis Chapman into the rotation next year, today’s announcement will surely give them pause.
Former Rangers closer Neftali Feliz will undergo Tommy John surgery and miss most or all of 2013 after being diagnosed with a torn UCL in his elbow. It means two of this year’s three big relief-to-starting pitching conversions have gone awry, as Daniel Bard is currently trying to figure things out back in the pen at Triple-A Pawtucket.
For what it’s worth, the third has been a huge success, what with Chris Sale pitching in the All-Star Game for the White Sox. However, that came with a hiccup, as concerns about his elbow prompted the White Sox to shift Sale back to the pen briefly in May. It was thought to be a permanent conversion, with Sale going into the closer’s role, but the left-hander was able to talk them out of it.
Personally, I’ve always felt that midseason relief-to-SP conversions were a bad idea. The Braves are actually trying that again with Kris Medlen now, even though the same switch two years ago likely led to his need for Tommy John surgery. The Padres tried it with Andrew Cashner this year, and he quickly landed on the DL, though not with an arm problem.
The Rangers, Red Sox and White Sox all prepared their youngsters as best they could, using them as starters in spring training and going slowly with them. Feliz got off to a nice start after the move, going 3-1 with a 3.16 ERA in 42 2/3 innings, but his elbow put him on the DL in mid-May. Bard was simply horribly inconsistent in going 5-6 with a 5.24 ERA. He had a 34/37 K/BB ratio in 55 innings.
Chapman was the big name some thought might go from the pen to the rotation next year, but he’s been so strong in as a reliever that it’d take a lot of guts for the Reds to make the switch. There aren’t many other youngsters likely to make the move. The Cubs could try turning Arodys Vizcaino back into a starter next year after getting him from the Braves in Monday’s Paul Maholm-Reed Johnson deal. He’s missed the entire 2012 season following Tommy John surgery. Tampa Bay’s Wade Davis, a starter throughout his career until this year, could be put back into the rotation if traded, but he seems to have come along nicely as a reliever and is probably better off there.
According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.
A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.
Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.
Espinosa will reach free agency after the 2017 season.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.